Treatment of Bickerstaff's brainstem encephalitis with immune globulin

Journal of the Neurological Sciences

Volumn 178, Issue 2, 2000, Pages 88-90

  Fox, Robert J ^a   Kasner, Scott E ^a   Galetta, Steven L ^a   Chalela, Julio A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anti GQ1b antibody; Bickerstaff's brainstem encephalitis; Intravenous immunoglobulin; IVIg; Ophthalmoparesis; Pseudoptosis; Pseudoretraction

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; BICKERSTAFF BRAINSTEM ENCEPHALITIS; BRAIN STEM INJURY; CASE REPORT; CLINICAL FEATURE; ENCEPHALITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; MALE; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PTOSIS; STEROID THERAPY;

ADULT; BRAIN STEM; CASE REPORT; ENCEPHALITIS; HUMAN; IMMUNOGLOBULINS, INTRAVENOUS; MALE; TREATMENT OUTCOME;

EID: 0034665252     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00379-8     Document Type: Article

References (14)

1. Bickerstaff E.R. Brain-stem encephalitis: further observations on a grave syndrome with benign prognosis. Br Med J. 1:1957;1384-1387.
2. Al-Din A.N., Anderson M., Bickerstaff E.R., Harvey I. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 105:1982;481-495.
3. Yaqub B.A., Al-Deeb S.M., Daif A.K., Sharif H.S., Shamena A.R., Al-Jaberi M., Obeid T., Panayiotopoulos C.C. Bickerstaff brainstem encephalitis: a grave non-demyelinating disease with benign prognosis. J Neurol Sci. 96:1990;29-40.
4. Koga M., Yuki N., Hirata K. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom. J Neurol Neurosurg Psychiatry. 66:1999;513-516.
5. Yuki N., Sato S., Tsuji S., Hozumi I., Miyatake T. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci. 118:1993;83-87.
6. Yuki N. Successful plasmapheresis in Bickerstaff's brain stem encephalitis associated with anti-GQ1b antibody. J Neurol Sci. 131:1995;108-110.
7. van der Meché F.G.A., Schmitz P.I.M. The Dutch Guillain-Barré Study Group. A radomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med. 326:1992;1123-1129.
8. Zifko U., Drlicek M., Senautka G., Grisold W. High dose immunoglobulin therapy is effective in the Miller Fisher syndrome. J Neurol. 241:1994;178-179.
9. Chiba A., Kusonoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 31:1992;677-679.
10. Al-Din A.S.N. The nosological position of the ophthalmoplegia, ataxia and areflexia syndrome: "The spectrum hypothesis" Acta Neurol Scand. 75:1987;287-294.
11. Yuki N., Wakabayashi K., Yamada M., Seki K. Overlap of Guillain-Barré syndrome and Bickerstaff's brainstem encephalitis. J Neurol Sci. 145:1997;119-121.
12. Dalakas M.C. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases. Neurology. 51:(Suppl 5):1998;S2-S8.
13. Cogan D.C. Paralysis of down-gaze. Arch Ophthalmol. 91:1974;192-199.
14. LoBue T.D., Feldon S.E. Reverse Collier's sign: pseudoblepharoptosis associated with downgaze paralysis. Am J Ophthalmol. 95:1983;120-121.